Rupam Manna/LinkedIn
May 9, 2026, 22:18
Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on LinkedIn:
”Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery!
From definition and grading to all causes (CIT, marrow infiltration, radiation, immune-mediated, hypersplenism, DIC) – clinical manifestations – evaluation – platelet thresholds for chemo and procedures – impact on treatment outcomes.
Key sections:
- Common culprit drugs (carboplatin, gemcitabine, temozolomide, PARP inhibitors, checkpoint inhibitors & more)
- Practical platelet thresholds for chemo, central lines, LP, surgery
- Treatment ladder: Transfusions, chemo modification, TPO-RAs (romiplostim, eltrombopag, avatrombopag)
- Prophylaxis and important oncology pearls (carboplatin nadir, persistent thrombocytopenia clues)
Reduces delays, dose reductions and improves quality of life plus survival!”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy